ConductScience.org, home

Paper4158055

Exclusive occurrence of K chains in isolated cold haemagglutinins.

Harboe M and 4 others. Scand J Haematol, 1965. Cited by 131 papers, by iCite.

Cite this record

ConductScience Library. Exclusive occurrence of K chains in isolated cold haemagglutinins. Papers, record 4158055. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4158055

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Exclusive occurrence of K chains in isolated cold haemagglutinins.
PubMed
Journal
Scand J Haematol
PubMed
Year
1965
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
131
iCite
Revised in PubMed
2019-09-08
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Harboe MM
2van Furth RR
3Schubothe HH
4Lind KK
5Evans RSR S

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AntibodiesMajor topic
Hemagglutination
Immune Sera
Immunodiffusion
Immunoelectrophoresis
gamma-Globulins

Cited by35

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 131 citations.

PMIDTitleJournalYearIn PapersSource
41789059Framework-mediated binding of foreign and self-glycans by IGHV4-34 antibodies.Front Immunol2026https://conductscience.org/library/papers/41789059PubMed
38874820Cold-antibody Autoimmune Hemolytic Anemia: its Association with Neoplastic Disease and Impact on Therapy.Curr Oncol Rep2024https://conductscience.org/library/papers/38874820PubMed
37168855The choice of new treatments in autoimmune hemolytic anemia: how to pick from the basket?Front Immunol2023https://conductscience.org/library/papers/37168855PubMed
37153870Sutimlimab for the Treatment of Cold Agglutinin Disease.Hemasphere2023https://conductscience.org/library/papers/37153870PubMed
33322221Rituximab Use in Warm and Cold Autoimmune Hemolytic Anemia.J Clin Med2020https://conductscience.org/library/papers/33322221PubMed
32318071New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia.Front Immunol2020https://conductscience.org/library/papers/32318071PubMed
31523413Novel insights into the treatment of complement-mediated hemolytic anemias.Ther Adv Hematol2019https://conductscience.org/library/papers/31523413PubMed
31114413Cold agglutinin disease: current challenges and future prospects.J Blood Med2019https://conductscience.org/library/papers/31114413PubMed
30949369Development of Multiple Myeloma of the IgA Type in a Patient with Cold Agglutinin Disease: Transformation or Coincidence?Case Rep Hematol2019https://conductscience.org/library/papers/30949369PubMed
30667771Antibodies without Antigenic Stimulation.J R Coll Physicians Lond1968https://conductscience.org/library/papers/30667771PubMed
27913484Cold agglutinin disease.Hematology Am Soc Hematol Educ Program2016https://conductscience.org/library/papers/27913484PubMed
26696798Role of Complement in Autoimmune Hemolytic Anemia.Transfus Med Hemother2015https://conductscience.org/library/papers/26696798PubMed
26696796New Insights in the Pathogenesis of Autoimmune Hemolytic Anemia.Transfus Med Hemother2015https://conductscience.org/library/papers/26696796PubMed
25705656Red blood cell destruction in autoimmune hemolytic anemia: role of complement and potential new targets for therapy.Biomed Res Int2015https://conductscience.org/library/papers/25705656PubMed
23399355Therapy for chronic cold agglutinin disease: perspective for further improvements.Blood Transfus2013https://conductscience.org/library/papers/23399355PubMed
17891600Primary chronic cold agglutinin disease: an update on pathogenesis, clinical features and therapy.Hematology2007https://conductscience.org/library/papers/17891600PubMed
7323952Protein synthesis in rheumatoid synovial tissue.Springer Semin Immunopathol1981https://conductscience.org/library/papers/7323952PubMed
6018754The immunologic character of acquired inhibitors of antihemophilic globulin (factor 8) and the kinetics of their interaction with factor 8.J Clin Invest1967https://conductscience.org/library/papers/6018754PubMed
5924621Heterogeneity of cold haemagglutinins.Immunology1966https://conductscience.org/library/papers/5924621PubMed
5664402Chemical differences between individual human cold agglutinins.Immunology1968https://conductscience.org/library/papers/5664402PubMed

See all 35 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4158055

GET https://conductscience.org/api/papers/v1/4158055/cited_by?page=2